GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
Gout is a type of inflammatory arthritis. It occurs when your blood has a buildup of uric acid. This acid causes crystals to form in a joint, which leads to ...
GlobalData on MSN
Arthrosi gains $153m for development of gout therapy
US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is ...
For researchers, including Georgetown University chemist Jennifer Swift, analyzing reptilian pee crystals presented an ...
Crystals "peed" by snakes could hold the key to treating kidney stones and gout in humans, say scientists. Researchers ...
Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys Therapeutics, Inc. (“Crystalys”), in which Urica ...
Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...
MedPage Today on MSN
Tainted Egg Warning; Dialysis Clinic Investigation; Gout Drug Flops for Long COVID
The FDA warned that Kenz Henz recalled some of its eggs due to potential Salmonella contamination. Republican leaders are ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
TipRanks on MSN
XORTX Therapeutics Announces US$1.1 Million Direct Offering
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 21, 2025, XORTX Therapeutics Inc. announced a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback